In the same line, reduction of NAMPT-derived NAD+ via pharmacological inhibition of NAMPT reduced the pathological changes in psoriasis [57] and atopic dermatitis [58] and diminished the expression of pro-inflammatory biomarkers. This evidence concerns the gene NAMPT and psoriasis.